Logo Image
Opinion|Videos|November 27, 2024

Navigating Healthcare Access and Decision-Making

Key Takeaways

  • Integrating HER2-directed therapies into NSCLC treatment requires alignment with existing protocols and timely updates to decision-making processes.
  • Establishing frameworks for rapid incorporation of emerging therapies and fostering adaptive decision-making processes are essential strategies.
SHOW MORE

An analysis of challenges and strategies for integrating HER2-directed therapies into decision-making for NSCLC, with a focus on timely updates, collaborative efforts among stakeholders, and balancing equitable access with cost management.

Episodes in this series

Video content above is prompted by the following:

  • What are the key challenges in integrating HER2-directed therapies into existing internal decision-making processes for NSCLC?
  • What strategies can be employed to ensure timely updates to internal decision-making processes as new HER2-directed therapies emerge?
  • How can collaboration between payers, providers, and manufacturers be leveraged to ensure equitable access to HER2-directed therapies while managing costs?

Related Content